Premetrexed combined with paclitaxel in NSCLC phase I-II

被引：0
|
作者：
Stathopoulos, George P. [1 ]
Dimitroulis, John [1 ]
Toubis, Michael [1 ]
Katis, Costas [1 ]
Karaindros, Dimitris [1 ]
Stathopoulos, John [1 ]
Koutandos, John [1 ]
机构：
[1] Errikos Dunant Hosp, Solca Grp, Oncol Clin A, Athens, Greece
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：223 / 223
页数：1
相关论文
共 50 条
  • [31] ON THE MECHANISM OF I-II PHASE-TRANSITION OF DSP
    YAGI, T
    FERROELECTRICS, 1990, 109 : 63 - 68
  • [32] Phase I/II Trial of Nab-Paclitaxel or Paclitaxel Plus Carboplatin with Concurrent Radiation for Inoperable Stage IIIA/B NSCLC
    Laine, A.
    Iyengar, P.
    Westover, K.
    Christie, A.
    Smith, I.
    Shakeel, S.
    Attia, A.
    Villaruz, L.
    Gerber, D.
    Chen, Y.
    Spigel, D.
    Socinski, M.
    Choy, H.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2304 - S2304
  • [33] High efficacy of paclitaxel and doxorubicin as first-line therapy in advanced breast cancer: A phase I-II study
    De Lena, M
    Latorre, A
    Calabrese, P
    Catino, A
    Lorusso, V
    Mazzei, A
    Aloe, A
    JOURNAL OF CHEMOTHERAPY, 2000, 12 (04) : 367 - 373
  • [34] Combination of paclitaxel and etoposide in the treatment of advanced non-small cell lung cancer:: A phase I-II study
    Nanni, L
    Palomba, G
    Morelli, F
    Piano, A
    Simeone, A
    D'Alessandro, V
    Sirotovà, Z
    Capuano, G
    Rinaldi, B
    Lelli, G
    JOURNAL OF CHEMOTHERAPY, 2001, 13 (01) : 88 - 92
  • [35] Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I-II study
    Tibaldi, C
    Prochilo, T
    Russo, F
    Pennucci, MC
    Del Freo, A
    Innocenti, F
    Fabbri, A
    Falcone, A
    Conte, PF
    Baldini, E
    BRITISH JOURNAL OF CANCER, 2006, 94 (09) : 1263 - 1266
  • [36] A phase I-II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancer
    Gelmon, KA
    Tolcher, A
    O'Reilly, S
    Campbell, C
    Bryce, C
    Shenkier, T
    Ragaz, J
    Ayers, D
    Nakashima, L
    Rielly, S
    Dulude, H
    ANNALS OF ONCOLOGY, 1998, 9 (11) : 1247 - 1249
  • [37] Phase I-II study of biweekly paclitaxel administration with fixed-dose-rate cisplatin in advanced gastric cancer
    Yamaguchi K.
    Shimamura T.
    Komatsu Y.
    Takagane A.
    Yoshioka T.
    Saitoh S.
    Munakata M.
    Sakata Y.
    Sato T.
    Arai T.
    Saitoh H.
    Gastric Cancer, 2006, 9 (1) : 36 - 43
  • [38] Gabrinox: A phase I-II of nab-paclitaxel plus gemcitabine followed by FOLFIRINOX in metastatic pancreatic adenocarcinoma.
    Assenat, Eric
    De La Fouchardiere, Christelle
    Mollevi, Caroline
    Samalin, Emmanuelle
    Portales, Fabienne
    Desseigne, Francoise
    Carenco, Christophe
    Dupuy, Marie
    Lopez-Martinez, Ernesto
    Fiess, Catherine
    Mazard, Thibault
    Ychou, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Liposomal cisplatin combined with gemcitabine in pretreated advanced pancreatic cancer patients: A phase I-II study
    Stathopoulos, GP
    Boulikas, T
    Vougiouka, M
    Rigatos, SK
    Stathopoulos, JG
    ONCOLOGY REPORTS, 2006, 15 (05) : 1201 - 1204
  • [40] Phase I-II study of irinotecan combined with mitomycin-C in patients with advanced gastric cancer
    Yamao, T
    Shirao, K
    Matsumura, Y
    Muro, K
    Yamada, Y
    Goto, M
    Chin, K
    Shimada, Y
    ANNALS OF ONCOLOGY, 2001, 12 (12) : 1729 - 1735
12345